PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease

Affiliations

• ¹ 1] Department of Surgical Sciences (Dunedin), VU University Medical Center, Amsterdam, The Netherlands [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
• ² Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
• ³ 1] QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Queensland, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
• ⁴ 1] Centre for Inflammatory Bowel Disease, Fremantle Hospital, Fremantle, Western Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
• ⁵ 1] Flinders Medical Centre, Flinders University of South Australia, Bedford Park, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
• ⁶ 1] Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
• ⁷ 1] Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.